2269 · Wuxi Biologics (Cayman) Inc.
39.10
HKDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
HK$162.59B
PE
23.80
EV/EBITDA
13.6
DIV Yield
0%
Payout Ratio
0%
MQV Rating
3Neutral
As at 24/07/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- HALO 100
- HALO 200
- HALO 50
- HALO All
- HALO Price Momentum
Key Fundamentals
EPS 3 yr Growth
15.00%
EBITDA Margin
38.50%
Operating Cashflow
¥6,558m
Free Cash Flow Return
14.00%
ROIC
10.50%
Interest Coverage
58.60
Quick Ratio
3.00
Performance
52 weeks range
Low 28.48 - 44
Trade Value (12mth)
US$39,904,596.00
1 week
5.73%
1 month
18.13%
YTD
20.16%
1 year
38.16%
All time high
148.00
Additional Data
Shares Outstanding (Fully Diluted)
4,167m
HALO Sector
Healthcare
Next Company Report Date
23-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
CNY
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Neutral
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Strong
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Strong
Balance Sheet
Neutral
Valuation
News & Announcements
| Date | Event |
20 August 25Flash | |
26 March 25Flash | |
23 August 24Flash |